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Abstract
Background: Interleukin 1 beta (IL-1β) is found in bronchoalveolar lavage fluids from asthmatic patients
and plays an important role in normal immunoregulatory processes but also in pathophysiological
inflammatory responses. The present study was designed to investigate if IL-1β could be involved in the
development of airway hyperresponsiveness and if transcriptional mechanisms, epithelium contractile
factors and mitogen-activated protein kinase (MAPK) pathways are involved in IL-1β effect.
Methods:  The effect of IL-1β on 5-hydroxytryptamine (5-HT) induced bronchoconstriction was
evaluated in an in-vitro model for assessment of long-term effects of inflammatory mediators on the airway
smooth muscle. Murine tracheal segments were cultured up to 8 days in the absence or presence of IL-1β
with subsequent evaluation in a myograph system, along with mRNA quantification, focusing on the role
of the epithelium, acetylcholine release, transcriptional mechanisms and MAPK activity.
Results: During control conditions, 5-HT induced a relatively weak contraction. Presence of IL-1β
increased this response in a time- and concentration-dependent way. The increased concentration-effect
curves could be shifted rightwards in a parallel manner by ketanserin, a selective 5-HT2A receptor
antagonist, indicating that the responses are mediated by 5-HT2A receptors. The mRNA levels of 5-HT2A
receptors were not changed as a consequence of the IL-1β treatment and actinomycin D, a general
transcriptional inhibitor, failed to affect the contractile response, suggesting a non-transcriptional
mechanism behind this phenomenon. Neither the removal of the epithelium nor the addition of atropine
affected the IL-1β induced enhancement of 5-HT2A receptor-mediated contractile response. Application
of inhibitors for c-Jun N-terminal kinase (JNK), p38 and extracellular signal-regulated kinase 1 and 2 (ERK1/
2) showed that the signaling pathways for JNK and ERK1/2 dominated only in cultured segments (control)
whereas JNK and p38 dominated in segments treated with IL-1β.
Conclusion: IL-1β induces murine airway hyperresponsiveness, via a non-transcriptional up-regulation of
5-HT2A receptor-mediated contractile response. The increase of 5-HT contraction is unrelated to
epithelial and cholinergic factors, but is dependent on IL-1β-induced changes of MAPK pathways. The fact
that IL-1β can alter airway responses to contractile agents such as 5-HT, via alteration of the intracellular
MAPK signal transduction pathways, might provide a new concept for future treatment of asthma.
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Background
5-hydroxytryptamine (5-HT) in the airways can be
released from neuroendocrine cells, mast cells and plate-
lets [1] and increased blood levels, correlating with the
severity of asthma, have been reported [2]. 5-HT induces
bronchoconstriction in most mammalian species via G-
protein coupled receptors, termed 5-HT2A and 5-HT1A [3].
The former dominates clearly within murine airways [4],
but information regarding the mediator pathways
involved is somewhat contradicting. According to Moffatt
and co-workers, 5-HT induces relatively weak contrac-
tions through epithelial 5-HT2A receptors via pathways
involving muscarinic receptors [4], whereas Kummer and
co-workers have reported the 5-HT2A receptors induce epi-
thelium dependent contractions, unrelated to the mus-
carinic receptors, via a non-cholinergic contractile factor,
in addition to a direct stimulatory effect on the smooth
muscle [5].
Interleukin 1 beta (IL-1β) is one of the most pleiotropic
and potent cytokines, produced predominantly by acti-
vated monocytes and macrophages [1,6]. It is known to
play an important role in normal immunoregulatory
processes but also in pathophysiological inflammatory
responses [7,8]. Elevated levels of cytokines have been
found in the bronchoalveolar lavage fluids from asth-
matic patients [9], and the cytokines like tumor necrosis
factor-alpha (TNF-α) and IL-1β have been shown to affect
the airway smooth muscle response to various contractile
agonists, like bradykinin, methacholine and 5-HT
[10,11]. We have recently demonstrated that TNF-α
induces a transcription dependent up-regulation of brady-
kinin receptors in the airway smooth muscle, resulting in
an increased contractile response. This up-regulation
appears to be dependent on mitogen-activated protein
kinase (MAPK) pathways, like c-Jun N-terminal kinase
(JNK) and extracellular signal-regulated kinase 1 and 2
(ERK1/2) [12,13]. However, we have also demonstrated
that the same MAPK pathways are involved in IL-1β
induced down-regulation of endothelin B receptor-medi-
ated airway contractions [14]. Thus, the present study was
designed to investigate if IL-1β affects 5-HT induced air-
way contraction focusing on the roles of transcription and
MAPK activity and epithelium contractile factor. We have
demonstrated that IL-1β induces 5-HT2A receptor-medi-
ated hyperresponsiveness in the airway through MAPK
activation, non-transcriptional and epithelium-independ-
ent mechanisms.
Methods
Tissue preparation
10 weeks old male BALB/c J mice (MB A/S, Ry, Denmark)
were sacrificed by cervical dislocation, the whole trachea
was rapidly removed and placed into Dulbecco's Modi-
fied Eagle's Medium (DMEM, 4500 mg/l D-glucose, 110
mg/l sodium pyruvate, 584 mg/l L-glutamine), supple-
mented with penicillin (100 U/ml) and streptomycin
(100 μg/ml). The trachea was then dissected free of adher-
ing tissue under a microscope and cut into three to four
segments for subsequent organ culture. The experimental
protocols have been approved by Lund University Animal
Ethics Committee (M232-03).
Organ culture
After the dissection, the segments were placed individu-
ally into wells of a 96-well plate (Ultra-low attachment;
Sigma, St. Louis, MO, U.S.A.) with 300 μl serum free
DMEM culture medium incubated at 37°C in humidified
5% CO2 in air in the absence and presence of recombinant
murine IL-1β for the required time intervals (1, 2, 4 or 8
days). Segments were transferred into new wells contain-
ing fresh media including IL-1β every day.
Epithelium removal
The epithelium of trachea was removed by gentle per-
fusion with 0.1% Triton X-100 for 1 min [4]. The epithe-
lium was removed after the trachea had been cultured in
the absence and presence of IL-1β. The removal of epithe-
lium was verified by the absence of response to bradyki-
nin in segments pre-constricted by carbachol (1 μM).
In-vitro pharmacology
The cultured segments were immersed in temperature-
controlled (37°C) myograph bath (Organ Bath Model
700MO, J.P. Trading, Aarhus, Denmark) containing 5 ml
Krebs-Henseleit buffer solution (143 mM Na+, 5.9 mM K+,
1.5 mM Ca2+, 2.5 mM Mg2+, 128 mM Cl-, 1.2 mM H2PO4
2-
, 1.2 mM SO4
2-, 25 mM HCO3
- and 10 mM D-glucose).
The solution was continuously equilibrated with 5% CO2
in O2 to result in a stable pH of 7.4. Each tracheal segment
was mounted on two L-shaped metal prongs. One prong
was connected to a force-displacement transducer for con-
tinuous recording of isometric tension by the Chart soft-
ware (AD Instruments Ltd., Hastings, U.K.). The other
prong was connected to a displacement device, allowing
adjustment of the distance between the two parallel
prongs. Following equilibration, a pre-tension about 0.8
mN was applied to each segment and adjusted to this level
of tension for at least one hour [15]. Each segment was
then contracted with 60 mM KCl to test the contractile
function. To inhibit epithelial prostaglandin release, the
segments were incubated with 3 μM indomethacin 30
min before administration of 5-HT. At the end of the
experiments, a reference contraction of 1 mM carbachol
was induced.
Data Analysis
All data are expressed as mean values ± S.E.M. Contractile
responses to 5-HT in each segment were expressed as per-
cent of maximal contraction induced by 1 mM carbacholRespiratory Research 2007, 8:29 http://respiratory-research.com/content/8/1/29
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(% of Cch) or the absolute values (mN) in the experi-
ments with actinomycin D, atropine and three MAPK
inhibitors, since they affect the reference (carbachol)-
induced contraction. Each agonist concentration-effect
curve was fitted to the Hill equation using an iterative,
least square method (GraphPad Prism 4, San Diego,
U.S.A), to provide estimates of maximal contraction
(Emax) and pEC50 values (negative logarithm of the agonist
concentration that produces 50% of the maximal effect).
Two-way analysis of variance (ANOVA) with Bonferroni
post-test was used to compare the two corresponding data
points at each concentration of the two curves, and
unpaired Students' t-test with Welch's correction applied
for the comparison of pEC50 values (curve shift) and Emax.
The data and statistical analysis was performed by Graph-
Pad Prism 4 (San Diego, USA). P < 0.05 was considered as
statistically significant.
Chemicals
Recombinant murine IL-1β (R&D Systems, Abingdon,
U.K); SP600125 (anthrax (1,9-cd)pyrazol-6(2H)-one,
Calbiochem, Bad Sodem, Germany), SB203580 (4-[5-(4-
Fluorophenyl)-2-[4-(methylsulfonyl)phenyl]-1H-imida-
zol-4-yl]pyridine, Tocris-Cookson, Bristol, U.K), penicil-
lin and streptomycin (Life Technologies, Gathisburg,
U.S.A.), PD98059 (2-(2-amino-3-methoxyphenyl)-4H-1-
benzopyran-4-one), 5-hydroxytryptamine, ketanserin,
atropine, indomethacin, carbachol, dimethyl sulfoxide
(DMSO), KCl, Triton X-100, DMEM and Krebs-Henseleit
Buffer (Sigma, St. Louis, MO, U.S.A.).
mRNA study
Tracheal smooth muscle was isolated mechanically on an
ice tray under a microscope. The samples with and with-
out epithelium were stored in the RNAlater™ (QIAGEN
GmbH, Hilden, Germany) under -80°C until use for
extraction of total RNA. The tissues were homogenized
and the total RNA was extracted by using the RNeasy Mini
kit following the supplier's instructions (QIAGEN GmbH,
Hilden, Germany). The purity of total RNA was checked
by a spectrophotometer and the wavelength absorption
ratio (260/280 nm) was between 1.6 and 2.0 in all prepa-
rations. Reverse transcription of total RNA (0.3–0.4 μg) to
cDNA was carried out using Omniscript™ reverse tran-
scriptase kit (QIAGEN GmbH, Hilden, Germany) in 20 μl
volume reaction at 37°C for 1 h by using Mastercycler per-
sonal PCR machine (Eppendorf AG, Hamburg, Ger-
many).
Specific primers for the mouse 5-HT2A receptor, choline
acetyltransferase (ChAT) and house keeping gene β-actin
were designed by using Prime Express®  2.0 software
(Applied Biosystem, Forster city, CA, USA) and synthe-
sized by DNA Technology A/S (Aarhus, Denmark).
Sequences as follows:
5-HT2A receptor (GenBank: NM_172812):
Forward: 5'-GGG CCA AAT TAT CCT CCT TCA-3'
Reverse: 5'-ATC GTC CTT CGG CCT GC-3'
ChAT (GenBank: NM_009891):
Forward: 5'-CCT GGA TGG TCC AGG CAC T-3'
Reverse: 5'-GTC ATA CCA ACG ATT CGC TCC-3'
β-actin (GenBank; NM_007393)
Forward: 5'-TGG GTC AGA AGG ACT CCT ATG TG-3'
Reverse: 5'-CGT CCC AGT TGG TAA CAA TGC-3'
Real-time polymerase chain reaction (real-time PCR) was
performed with the QuantiTect™ SYBR® Green PCR kit
(QIAGEN GmbH, Hilden, Germany) in The Smart Cycler®
II system (Cepheid, Sunnyvale, CA, USA). The system
automatically monitors the binding of a fluorescent dye
SYBR® Green to double-stranded DNA by real-time detec-
tion of the fluorescence during each cycle of PCR amplifi-
cation. The real-time PCR was prepared in 25 μl reaction
volumes and carried out with heating 95°C for 15 min
followed by touch down PCR i.e. denature at 94°C for 30
sec and annealing at 66°C for 1 min for the first PCR
cycle, thereafter, a decrease of 2°C for the annealing tem-
perature in every cycle until 56°C. Finally, 40 thermal
cycles with 94°C for 30 sec and 55°C for 1 min were per-
formed. The data were analysed with the threshold cycle
(CT) method and the specificity of the PCR products was
checked by the dissociation curves and visualized by aga-
rose electrophoresis. Expected PCR products of 5-HT2A
receptor 111 bp, ChAT 102 bp and β-actin 102 bp with a
single band for each product were seen. A blank (no tem-
plate) was included in all the experiments for negative
controls.
The house keeping gene β-actin mRNA is continuously
expressed to a constant amount in the cells. We compared
its expression with expression to another house keeping
gene GAPDH in a pilot study by real-time PCR and found
no difference in the expression between the two house
keeping genes. β-actin was used as a reference in this
study, but both were equally constant in the tests. The rel-
ative amount of mRNA was obtained by the CT values of
mRNA for 5-HT2A receptor or ChAT in relation to the CT
values of mRNA for house keeping gene β-actin in the
same sample by the formula X0/R0 = 2CtR-CtX, where X0 is
the original amount of target mRNA, R0 is the original
amount of β-actin mRNAs, CtR is the CT value for β-actin
mRNAs, and CTX is the CT value for the target. Data areRespiratory Research 2007, 8:29 http://respiratory-research.com/content/8/1/29
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Time-course for IL-1β effects on the 5-HT response Figure 1
Time-course for IL-1β effects on the 5-HT response. Tracheal segments cultured for 1 day (A), 2 days (B), 4 days (C) or 
8 days (D) in the absence (control) and presence of IL-1β (10 ng/ml). Statistical analysis was performed with two-way ANOVA 
with Bonferroni post-test to compare the two corresponding data points at each concentration of the two curves. Each data 
point is derived from 6–18 experiments and represented as mean ± S.E.M. *P < 0.05, compared with control.Respiratory Research 2007, 8:29 http://respiratory-research.com/content/8/1/29
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presented as mean ± S.E.M. Statistical analyses were used
with unpaired Students' t-test with Welch's correction. P <
0.05 was considered to be significant.
Results
Up-regulation of 5-HT-induced contraction
Tracheal segments were cultured in the absence and pres-
ence of IL-1β (10 ng/ml) for 1, 2, 4 or 8 days. A significant
increase of the maximal contractile response to 5-HT was
seen at 1 day, and this up-regulation became further
enhanced when the culture periods were extended. The
pEC50 values remained unaltered over time (Fig. 1A–D).
When tracheal segments were cultured for 4 days in the
presence of different concentrations of IL-1β (0.1, 1, 10 or
100 ng/ml), the 5-HT response increased in a concentra-
tion-dependent way. IL-1β concentrations higher than 10
ng/ml did not further increase the contractions. The pEC50
values remained the same in all groups (Fig. 2).
IL-1β (10 ng/ml) did not affect carbachol-induced maxi-
mal contraction in the segments cultured for 1 day (con-
trol Emax = 7.9 ± 0.7 vs. IL-1β Emax = 7.1 ± 1.0 mN, n = 6),
2 days (control Emax = 6.5 ± 0.7 vs. IL-1β Emax = 6.6 ± 0.7
mN, n = 7), 4 days (control Emax = 6.1 ± 0.4 vs. IL-1β Emax
= 6.3 ± 1.0 mN, n = 6) and 8 days (control Emax = 3.6 ± 0.5
vs. IL-1β Emax = 3.5 ± 0.5 mN, n = 12).
Pharmacological characterization of 5-HT receptors
The contractile response curves for 5-HT in the segments
cultured for 4 days with IL-1β (10 ng/ml) were shifted to
the right in a parallel manner by ketanserin (a selective 5-
HT2A receptor antagonist) in the concentration of 1, 3 and
10 nM. The control pEC50 value (6.71 ± 0.05) in compar-
ison with ketanserin at 1 nM pEC50 (6.37 ± 0.09, n = 7–13,
P < 0.05), at 3 nM pEC50 (5.96 ± 0.09, n = 7–13, P < 0.001)
and at 10 nM pEC50 (5.52 ± 0.07, n = 5–13, P < 0.001)
were significantly higher (Fig. 3A), while the maximal
contraction was not affected (control Emax 68.4 ± 3.9% vs.
ketanserin at 1 nM Emax 67.8 ± 4.8%, at 3 nM Emax 64.6 ±
3.8 and at 10 nM Emax 77.1 ± 2.9%, n = 5–13, P > 0.05, Fig.
3A). A pKB value of 9.15 indicated that these contractions
were mediated mainly via 5-HT2A receptors (Fig. 3B) in
accordance with our previous results [15].
Role of transcription
The mRNA expression levels for the 5-HT2A receptors were
not affected by the presence of IL-1β (Fig. 4). Neither was
the contractile response induced by 5-HT after 1 day in
culture with IL-1β (10 ng/ml) affected by the presence of
actinomycin D (5 μg/ml), a general transcriptional inhib-
itor (P > 0.05, Fig. 5). Since actinomycin D affected the
contraction induced by the reference substance carbachol
(data not shown), the values are expressed in mN.
Together these experiments indicate that the increased 5-
HT2A receptor activity seen as the result of IL-1β pretreat-
ment appears to take place without changes at the tran-
scriptional level.
Role of acetylcholine
Choline acetyltransferase (ChAT) is responsible for acetyl-
choline production in all types of cell, including airway
epithelium, smooth muscle and neuronal tissues [16,17].
The mRNA levels of ChAT were similar in tracheal seg-
ments cultured for 4 days regardless of the eventual pres-
ence of IL-1β (Fig. 4). Atropine (1 μM) was added 1 hour
before administration of 5-HT [5,18]. In the fresh seg-
ments, atropine shifted 5-HT concentration response
curves to the right (control pEC50 5.92 ± 0.07 vs. atropine
pEC50 5.21 ± 0.07, n = 7–13, P < 0.001, Fig. 6A) with a ten-
dency of decrease in the maximal contraction (control
Emax 1.53 ± 0.28 vs. atropine Emax 1.18 ± 0.13 mN, n = 7–
13, P > 0.05, Fig. 6A). However, after the segments were
cultured for 4 days, both in absence and presence of IL-1β,
the contraction induced by 5-HT became atropine insen-
sitive i.e. no significant shifts of curves were seen after
application of atropine (P > 0.05, Fig. 6B–C).
Concentration-response curves for IL-1β effects on the 5- HT response Figure 2
Concentration-response curves for IL-1β effects on 
the 5-HT response. Tracheal segments cultured for 4 days 
in the presence of different concentrations of IL-1β (0.1, 1, 
10, 100 ng/ml). Each data point is derived from 6–16 experi-
ments and represented as the mean ± S.E.M. Statistical analy-
sis was performed with two-way ANOVA with Bonferroni 
post-test to compare the two corresponding data points at 
each concentration of the two curves. *P < 0.05, compared 
with control.Respiratory Research 2007, 8:29 http://respiratory-research.com/content/8/1/29
Page 6 of 12
(page number not for citation purposes)
Effects of epithelial removal
In order to ascertain if epithelium is involved in the up-
regulation of 5-HT-induced contraction, the epithelium
was removed after the trachea had been cultured for 4
days in the absence and presence of IL-1β (10 ng/ml).
Removal of epithelium did not affect the contractile
response to 5-HT in the fresh segments (P > 0.05, Fig. 7A)
and after treatment with IL-1β (P > 0.05, Fig. 7C), whereas
a not statistical significant increase was seen after organ
culture (P > 0.05, Fig. 7B). Neither was the mRNA level of
5-HT2A receptors nor the amount of ChAT affected by this
procedure (Fig. 4). This excludes a role for epithelial fac-
tors in the IL-1β induced 5-HT hyperresponsiveness.
Mitogen-activated protein kinase inhibition
In order to investigate whether intracellular JNK, p38 and
ERK1/2 were involved in the IL-1β induced up-regulation
of the 5-HT response, a series of experiments were per-
formed by use of the MAPK inhibitors SP600125 (10 μM),
SB203580 (10 μM) and PD98059 (100 μM), and vehicle
(DMSO) as control. The inhibitors were applied 30 min
prior to the first 5-HT concentration in either fresh seg-
ments or segments cultured for 4 days in the absence and
presence of IL-1β (10 ng/ml). In the fresh segments, 5-HT-
induced contraction was almost completely abolished by
SP600125, SB203580 and PD98059, with a reduction by
98%, 68% and 82%, respectively (Fig. 8A). Segments cul-
tured in the absence of IL-1β had a similar inhibitory pat-
tern (85% by SP600125, 21% by SB203580 and 60% by
PD98059, respectively) as the fresh segments, although
SB203580 had significantly less inhibitory effects (Fig.
8B). In segments treated with IL-1β, the inhibitory pattern
was altered (68% in SP600125, 56% in SB203580 and
22% in PD98059, respectively), which indicates that the
signalling was shifted from ERK1/2 to p38 in 5-HT-
induced contraction (Fig. 8C). Taken together these data
indicate that MAPK activities are required for 5-HT2A
receptors-mediated contraction and that IL-1β induces an
increased contraction to 5-HT by interference with MAPK
pathways.
Discussion
The present study demonstrates that long-term exposure
of IL-1β increased the contractile response to 5-HT reflect-
ing the development of airway hyperresponsiveness.
Experiments with ketanserin indicated that the contrac-
tion was mediated via 5-HT2A receptors and since epithe-
lial removal did not affect the outcome, these receptors
Receptor characterization Figure 3
Receptor characterization. Effect of the selective 5-HT2A receptor antagonist, ketanserin (1–10 nM) on 5-HT induced con-
traction in the tracheal segments cultured for 4 days with IL-1β (10 ng/ml) (A). Ketanserin was added to the tissue bath 30 min 
before the first concentration of 5-HT. Each data point is derived from 5–13 experiments and represented as the mean ± 
S.E.M. Statistical analysis was performed with two-way ANOVA with Bonferroni post-test to compare the two corresponding 
data points at each concentration of the two curves (Fig. 3A), and unpaired Students' t-test with Welch's correction applied for 
the comparison of pEC50 values (curve shift) and the Emax (see results). *P < 0.05, compared with control. Schild analysis of data 
derived from panel A (B).Respiratory Research 2007, 8:29 http://respiratory-research.com/content/8/1/29
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must be situated direct on the airway smooth muscle. The
mRNA levels of the 5-HT2A receptors were not changed as
a consequence of the IL-1β treatment which suggests that
these events might be regulated on a post-transcriptional
level, an argument further supported by the failure of
actinomycin D to affect the outcome. The experiments
with a set of specific JNK, ERK1/2 and p38 inhibitors indi-
cated that the increase in 5-HT2A receptor activities was
most likely dependent on IL-1β-induced alteration of
MAPK pathways.
Organ culture has been used as a model to study altera-
tion of G-protein coupled receptor in airway smooth mus-
cle cells that associates with airway hyperresponsiveness.
Moir and colleagues reported that organ culture of human
intact bronchiole ring segments in serum free culture
medium up to 6 days maintains its functional, biochemi-
cal and morphometric properties [19]. Smooth muscle-
alpha-actin, myosin heavy chain isoform 1 expression,
nonmuscle proteins, including total vinculin, beta-actin
and nonmuscle myosin heavy chain were unchanged dur-
ing the culture [19]. This agrees well with our previously
report that organ culture of mouse tracheal segments in
serum-free culture medium up to 16 days, the morphol-
ogy and contractility of smooth muscle cells appeared to
be maintained throughout the culture period [15]. By
using the same model, we demonstrated that organ cul-
ture up-regulated bradykinin B1 and B2 receptors in the
airway at transcriptional level [12,13]. The slight reduc-
tion of maximal contraction in response to 5-HT in organ
culture in the present study could therefore be associated
with the airway inflammation. This has been demon-
strated by applying dexamethasone in the organ culture
and seen that dexamethasone could abolish the reduced
contractile response to 5-HT (unpublished data).
5-HT is released by neuroendocrine cells in the airways of
animals and humans, its role in airway tone is not well
understood [20]. During control conditions, 5-HT has
been reported to show some effects in respiratory tissues
by activation of different subtype receptors. It has been
demonstrated that 5-HT2A receptor activation causes air-
way contraction in-vivo and in-vitro, and enhances effects
of cholinergic nerve-mediated responses, whereas 5-HT1A
receptor activation generally seems to be related to a relax-
ant effect [21-24]. In the present set-up, IL-1β induced a
significant time- and concentration-dependent up-regula-
tion of the contractile 5-HT response. Since ketanserin
Effect of actinomycin D on the IL-1β enhanced 5-HT induced  contraction Figure 5
Effect of actinomycin D on the IL-1β enhanced 5-HT 
induced contraction. The tracheal segments were cul-
tured for 1 day in the presence of IL-1β (10 ng/ml) with and 
without actinomycin D (ACD, 5 μg/ml). Each data point is 
derived from 7–18 experiments and represented as the mean 
± S.E.M. Statistical analysis was performed with two-way 
ANOVA with Bonferroni post-test to compare the two cor-
responding data points at each concentration of the two 
curves, no significant differences were seen (P > 0.05).
mRNA expression for 5-HT2A receptors and choline acetyl- transferase (ChAT) Figure 4
mRNA expression for 5-HT2A receptors and choline 
acetyltransferase (ChAT). The trachea cultured in the 
absence (control) and presence of IL-1β (10 ng/ml). A 2-day 
culture period was used for experiments with intact epithe-
lium and 4 days period for denuded segments. Each data 
point is derived from 2–5 experiments. Each value was 
derived from 3 mice and presented as mean ± S.E.M. 
Unpaired student's t-test with Welch's correction were used 
for statistic analysis. N.S. = not significant. Epi+ = with epithe-
lium, Epi- = without epithelium.Respiratory Research 2007, 8:29 http://respiratory-research.com/content/8/1/29
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Effect of atropine on 5-HT-induced contraction Figure 6
Effect of atropine on 5-HT-induced contraction. Atropine (1 μM) was added 1 hour before administration of the 5-HT 
concentration effect curves. Fresh (A), 4 days of organ culture in the absence (B) and presence (C) of IL-1β (10 ng/ml). Each 
data point is derived from 6–11 experiments and represented as the mean ± S.E.M. Statistical analysis was performed with two-
way ANOVA with Bonferroni post-test to compare the two corresponding data points at each concentration, no differences 
were seen (Fig. 6A-C, P > 0.05). In addition, unpaired Students' t-test with Welch's correction was applied for comparison of 
pEC50 values (curve shift) and maximal contraction of the two corresponding curves (see results).Respiratory Research 2007, 8:29 http://respiratory-research.com/content/8/1/29
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Effect of epithelium removal on 5-HT-induced contraction Figure 7
Effect of epithelium removal on 5-HT-induced contraction. Fresh (A), 4 days of organ culture in the absence (B) and 
presence (C) of IL-1β (10 ng/ml). Epithelium was removed after the trachea had been organ cultured in the absence and pres-
ence of IL-1β. The results were compared with data obtained in segments with an intact epithelium. Each data point is derived 
from 5–10 experiments and represented as the mean ± S.E.M. Statistical analysis was performed with two-way ANOVA with 
Bonferroni post-test to compare the two corresponding data points at each concentration, no significant differences were seen 
(P > 0.05).Respiratory Research 2007, 8:29 http://respiratory-research.com/content/8/1/29
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MAPK inhibition Figure 8
MAPK inhibition. Effect of specific inhibitors for JNK (SP600125), ERK 1/2 (PD98059) or p38 (SB203580) on 5-HT induced 
contractions. Fresh (A), 4 days of organ culture in the absence (B) and presence (C) of IL-1β (10 ng/ml). The three inhibitors as 
well as the vehicle (DMSO) were added to the tissue bath 30 min before the first concentration of 5-HT. Each data point is 
derived from 5–6 experiments and represented as mean ± S.E.M. Statistical analysis was performed with two-way ANOVA 
with Bonferroni post-test to compare the two corresponding data points at each concentration of the two curves. *P < 0.05, 
compared with control.Respiratory Research 2007, 8:29 http://respiratory-research.com/content/8/1/29
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competitively antagonized the 5-HT-induced contraction
with a pKB value 9.15 in accordance with 9.4 in mouse
aorta [25], we could demonstrate that the contraction was
mediated via 5-HT2A receptors. In analogy with a contrac-
tile role for 5-HT2A receptors in the airway, ketanserin, has
been demonstrated to decrease ovalbumin-induced air-
way hyperresponsiveness in mouse [26] and to be benefi-
cial in asthmatic subjects [27].
Release of epithelium-derived acetylcholine has been sug-
gested to be an important factor in the development of the
excessive tone often seen in murine and human airways
following their exposure to different inflammatory medi-
ators [4,28-30]. Accordingly, 5-HT is reported to induce
an atropine sensitive bronchoconstriction in mice [18], an
effect traditionally interpreted as mediated via cholinergic
parasympathetic nerve fibers innervating the airway
smooth muscles. However, recent findings suggest that
the cholinergic contractile response to 5-HT in the mouse
isolated trachea might depend on a non-neuronal source
of acetylcholine, most likely the airway epithelium [4]. An
atropine sensitive 5-HT response was also seen in the
present set-up during fresh conditions, in accordance with
a release of acetylcholine. In contrast, the 5-HT2A receptor-
mediated contractions seen following long-term exposure
to IL-1β appeared to be independent of both atropine and
epithelium. Since ILs have been shown to increase ChAT
activity and mRNA expression in the neuron cell culture
[31,32], ChAT mRNA expression were quantified by real-
time PCR in the present study, but no significant differ-
ences in ChAT mRNA expression between IL-1β and con-
trol groups were found. This together with that atropine
failed to antagonize the 5-HT-induced contraction in the
segments after IL-1β treatment, suggest an attenuated
cholinergic signaling after IL-1β treatment regarding to 5-
HT contractile response. Since no differences in carba-
chol-induced contraction between IL-1β and control
groups were found, the mechanisms behind this is there-
fore most likely due to reduction of neural or non-neural
acetylcholine production from surrounding tissues.
It is well known that 5-HT induced activation of 5-HT2A
receptors results in intracellular phosphatidylinositol
turnover and mobilization of Ca2+ [33-35]. Studies have
also demonstrated that 5-HT2A receptor-mediated contrac-
tions require activation of the intracellular MAPK ERK1/2
pathway [36,37]. The evaluation of acute effects of the
MAPK inhibitors rather than their long-term effects is jus-
tified by the lack of transcriptional effects of IL-1β. In con-
cert with this, the present study showed that acute
inhibition of JNK, ERK1/2 or p38 activity decreased the
contraction induced by 5-HT in fresh segments. However,
in cultured segments the effect through p38 was
decreased. When segments were treated with IL-1β, the
effect through the ERK1/2 pathway was reduced concom-
itant with a strong effect through p38. The ability for IL-1β
to interfere directly with MAPK pathways to raise the basic
level of intracellular free Ca2+ [38], can be the reason for
the increased sensitivity to 5-HT stimulation.
Conclusion
To summarize, the present study demonstrates that IL-1β
can induce murine airway hyperresponsiveness, via a non-
transcriptional up-regulation of 5-HT2A mediated contrac-
tile response through an alteration of the MAPK pathways.
The fact that pro-inflammatory cytokines like IL-1β can
alter airway contractile responses to contractile agents
such as 5-HT, via interference with the intracellular MAPK
signal transduction pathways, might provide a new con-
cept for the treatment of asthma. Thus, a future therapeu-
tic approach could be aimed to target the intracellular "on
and off switch" for contractile airway receptors.
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